![ArisGlobal Newscast: Industry’s Only E2B R3 Compliant Safety Multi-Tenant Cloud Platform](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
LifeSphere® Safety MultiVigilance is the only E2B R3 compliant multi-tenant cloud solution in the safety market. Customers already…
Learn More![Connected to the Future: Making Drug Safety Databases Transparent, E2B R3 Compliant and Cost-Effective](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
As different regulatory authorities have different timelines for adoption of these standards, E2B(R2) E2B(R3) will have to coexist. But having to operate two solutions creates huge complexities, unless you find a solution compliant with both. ArisGlobal LifeSphere Safety MultiVigilance is the only drug safety database solution provider thus far to provide full compliance to E2B R2 and E2B R3 standards for both import and export.
Learn More![Blog: Automation in ICSR Processing – Is Artificial Intelligence the Paradigm Shift in Pharmacovigilance?](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world…
Learn More![What to Look Forward to in Clinical Trial Innovations in 2017](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
The clinical trial sector witnessed a lot of action in 2016. Pharmaceutical establishments are increasing their focus on this branch…
Learn More![Breaking Down Silos across the Life Sciences Enterprise Helps Drive Innovation](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Silos have long plagued the life sciences industry, and nowhere is this more notable than with how information and data…
Learn MoreToday’s Medical Information (MI) and Medical Affairs professionals are juggling multiple challenges: they must adapt to decentralization, outsourcing and globalization…
Learn MoreSafety departments at Marketing Authorization Holders & Regulatory Authorities are under pressure from all sides. They must constantly stay on…
Learn MoreRising Expectations from Regulatory Affairs Executives As we all know from experience, not all cloud solutions are the same and…
Learn MoreArtificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world as we know it. While there’s a lot of talk about how AI will affect jobs, where it will have the most powerful impact is on the quality of work and the speed at which manual tasks can be accomplished.
Learn MoreThis is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working practices and opening doors to better ways of collaborating, tracking and sharing documents and data, and gaining clear oversight into the product supply chain.
Learn More